Wedbush Securities Inc Sorrento Therapeutics, Inc. Transaction History

Wedbush Securities Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.17 - $1.19 $334 - $2,344	-1,970 Reduced 10.77%	16,330 $6,000
Q1 2022 Apr 19, 2022	BUY	$2.0 - $4.9 $600 - $1,470	300 Added 1.67%	18,300 $42,000
Q4 2021 Jan 13, 2022	BUY	$4.65 - $7.23 $11,625 - $18,075	2,500 Added 16.13%	18,000 $83,000
Q3 2021 Oct 08, 2021	BUY	$7.41 - $10.99 $25,935 - $38,465	3,500 Added 29.17%	15,500 $118,000
Q2 2021 Jul 27, 2021	BUY	$6.35 - $10.0 $76,200 - $120,000	12,000 New	12,000 $116,000
Q1 2021 Apr 26, 2021	SELL	$7.03 - $16.51 $75,221 - $176,657	-10,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $61,632 - $127,864	10,700 New	10,700 $73,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.